Artificial Intelligence in Biomedical Research -A lecture by Prof. W. Minor

The history of drug discovery is as long as the history of humanity. In ancient times, drug discovery was an empirical process deeply rooted in observing nature and transmitting knowledge. Early human societies relied on herbs and minerals to treat diseases and wounds. Traditional medicine systems persist in many countries today. However, drug discovery evolved toward using scientifically rigorous technology and modern observation tools that allow us to make observations on a molecular level. One of the most promising tools in this evolution is artificial intelligence, which has the potential to revolutionize biomedical research by enhancing the efficiency, accuracy, and speed of identifying new drug candidates. However, this powerful tool must be used correctly and with great care.

Władysław Minor also known as Wladek Minor (born 1946) is a Polish-American biophysicist, a specialist in structural biology and protein crystallography. He is a Harrison Distinguished Professor of Molecular Physiology and Biological Physics at the University of Virginia. Minor is a co-author of HKL2000/HKL3000 – crystallographic data processing and structure solution software used to process data and solve structures of macromolecules and small molecules. He co-founded HKL Research, a company that distributes the software. He is also a co-author of a public repository of diffraction images (proteindiffraction.org) for some of the protein structures available in the Protein Data Bank and other software tools for structural biology.

A wine reception will follow the lecture. The event is part of the KF Collegium of Eminent Scientists Lecture Series.

Host or Publisher The Kosciuszko Foundation